APGEApogee Therapeutics - Common StockAPGE info
$47.71info1.47%24h
Global rank4753
Market cap$2.29B
Change 7d4.06%
YTD Performance73.81%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Apogee Therapeutics - Common Stock (APGE) Stock Overview

    Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.

    APGE Stock Information

    Symbol
    APGE
    Address
    221 Crescent StreetWaltham, MA 02453United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.apogeetherapeutics.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    650-394-5230

    Apogee Therapeutics - Common Stock (APGE) Price Chart

    -
    Value:-

    Apogee Therapeutics - Common Stock Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $47.71
    N/A
    Market Cap
    $2.29B
    N/A
    Shares Outstanding
    48.02M
    N/A
    Employees
    0
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org